Ductal adenocarcinoma (DAC) is the most common variant histological subtype of prostate
carcinoma and has an aggressive clinical course. DAC is usually characterized and treated …

Context Ductal adenocarcinoma (DAC) is relatively rare, but is nonetheless the second most
common subtype of prostate cancer. First described in 1967, opinion is still divided …

Background To assess cancer-specific mortality (CSM) and other-cause mortality (OCM)
rates in patients with rare histological prostate cancer subtypes. Methods Using the …

Background Ductal prostate adenocarcinoma (DAC) is a rare, aggressive, histologic variant
of prostate cancer that is treated with conventional therapies, similar to high-risk prostate …

Survival differences in rare histological prostate cancer (PCa) subtypes relative to age‐
matched population‐based controls are unknown. Within Surveillance, Epidemiology, and …

Ductal adenocarcinoma of the prostate (DAC) is recognised as a subtype of prostatic
adenocarcinoma, but its diagnostic criteria and biology remain controversial. DAC was first …

Purpose To investigate clinicopathologic characteristics and cancer-specific mortality (CSM)
rates of ductal carcinoma (DC) versus the common acinar adenocarcinoma in nonmetastatic …

There are some current literatures describing the morphologic change of prostate carcinoma
variants. Some subtypes do not respond to hormone deprivation therapy, for example …

Background Ductal adenocarcinoma of the prostate is an aggressive subtype, with high
rates of biochemical recurrence and overall poor prognosis. It is frequently found coincident …

Background Ductal adenocarcinoma (DAC) is a rare and aggressive subtype of prostate
cancer (PCa). In the present study, we analyzed the clinical and biological characteristics of …